Assignee
ASTRAZENECA AB
US·1,272 granted patents·1,092 pending applications·17,198 citations·filing 1994–2025
Top patents by PatentIndex Score
2,364 records- 0198US12054465B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2023·Granted Aug 6, 2024·3 cites·21 claims
- 0298US11814359B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Nov 14, 2023·4 cites·21 claims
- 0398US11773069B2Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Oct 3, 2023·6 cites·23 claims
- 0498US11680049B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 20, 2023·5 cites·14 claims
- 0598US11117874B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2020·Granted Sep 14, 2021·15 cites·60 claims
- 0698US10669245B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2019·Granted Jun 2, 2020·16 cites·16 claims
- 0798US9815805B2Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2016·Granted Nov 14, 2017·22 cites·14 claims
- 0898USD450382SCatheterASTRAZENECA AB·Filed 2000·Granted Nov 13, 2001·140 cites·1 claims
- 0997US11673871B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·20 claims
- 1097US11673872B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted Jun 13, 2023·5 cites·14 claims
- 1197US11667615B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2021·Granted Jun 6, 2023·5 cites·15 claims
- 1297US11655222B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1397US11655221B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·22 claims
- 1497US11655223B2Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·21 claims
- 1597US11655224B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2022·Granted May 23, 2023·5 cites·20 claims
- 1697US10287258B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2017·Granted May 14, 2019·18 cites·6 claims
- 1797US9522894B2Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2015·Granted Dec 20, 2016·25 cites·8 claims
- 1897US6919338B2Substituted quinazoline derivatives and their use as inhibitors of aurora-2 kinaseASTRAZENECA AB·Filed 2001·Granted Jul 19, 2005·103 cites·12 claims
- 1996US7524957B2Compounds effecting glucokinaseASTRAZENECA AB·Filed 2008·Granted Apr 28, 2009·31 cites·22 claims
- 2096US7500964B2Automatically operable safety shield system for syringesASTRAZENECA AB·Filed 2007·Granted Mar 10, 2009·108 cites·17 claims
- 2196US7112595B2Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2003·Granted Sep 26, 2006·92 cites·23 claims
- 2296USD448076SInhalerASTRAZENECA AB·Filed 1998·Granted Sep 18, 2001·56 cites·1 claims
- 2396US6189739B1Pump dispenser with threshold actuation and restoring springASTRAZENECA AB·Filed 1997·Granted Feb 20, 2001·133 cites·23 claims
- 2495US11912727B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2023·Granted Feb 27, 2024·4 cites·13 claims
- 2595US10273227B2C5-anilinoquinazoline compounds and their use in treating cancerASTRAZENECA AB·Filed 2018·Granted Apr 30, 2019·11 cites·24 claims
- 2695US9248140B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Feb 2, 2016·31 cites·6 claims
- 2795US7125864B2Benzothiazepine derivatives for the treatment of hyperlipidemiaASTRAZENECA AB·Filed 2002·Granted Oct 24, 2006·86 cites·11 claims
- 2895US6908920B2Pyrimidine derivativesASTRAZENECA AB·Filed 2001·Granted Jun 21, 2005·124 cites·10 claims
- 2995US6875872B1CompoundsASTRAZENECA AB·Filed 2000·Granted Apr 5, 2005·43 cites·12 claims
- 3095US6838089B1Antigen delivery system and method of productionASTRAZENECA AB·Filed 1999·Granted Jan 4, 2005·196 cites·65 claims
- 3195US6838464B22,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agentsASTRAZENECA AB·Filed 2001·Granted Jan 4, 2005·183 cites·14 claims
- 3295US6593326B12,4-diamino pyrimidine compounds having anti-cell proliferative activityASTRAZENECA AB·Filed 1999·Granted Jul 15, 2003·317 cites·13 claims
- 3394US12195485B2Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2022·Granted Jan 14, 2025·4 cites·23 claims
- 3494US11813246B2Pharmaceutical compositionASTRAZENECA AB·Filed 2021·Granted Nov 14, 2023·7 cites·8 claims
- 3594US11325906B2Chemical compoundsASTRAZENECA AB·Filed 2020·Granted May 10, 2022·8 cites·2 claims
- 3694US7875715B2Compounds for the treatment of multi-drug resistant bacterial infectionsASTRAZENECA AB·Filed 2006·Granted Jan 25, 2011·13 cites·1 claims
- 3794US7745475B2Heteroaryl benzamide derivatives as GLK activatorsASTRAZENECA AB·Filed 2005·Granted Jun 29, 2010·14 cites·3 claims
- 3894US7696214B2Quinazoline derivatives for the treatment of tumoursASTRAZENECA AB·Filed 2005·Granted Apr 13, 2010·11 cites·5 claims
- 3994US7118552B2Automatically operable safety shield system for syringesASTRAZENECA AB·Filed 2001·Granted Oct 10, 2006·195 cites·20 claims
- 4094US6774122B2FormulationASTRAZENECA AB·Filed 2001·Granted Aug 10, 2004·68 cites·9 claims
- 4194USD455953SBlister packASTRAZENECA AB·Filed 2001·Granted Apr 23, 2002·44 cites·1 claims
- 4294USD455344SBlister packASTRAZENECA AB·Filed 2001·Granted Apr 9, 2002·47 cites·1 claims
- 4394US2026055067A1Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitorsASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 4493US7642259B2Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetesASTRAZENECA AB·Filed 2006·Granted Jan 5, 2010·18 cites·3 claims
- 4593US7585881B2Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonistsASTRAZENECA AB·Filed 2005·Granted Sep 8, 2009·36 cites·2 claims
- 4693US7485722B2Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2007·Granted Feb 3, 2009·29 cites·13 claims
- 4793US7250419B2Trisubstituted triazolopyrimidines for use in platelet aggregation inhibitionASTRAZENECA AB·Filed 2005·Granted Jul 31, 2007·16 cites·14 claims
- 4893US7238684B2Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing themASTRAZENECA AB·Filed 2003·Granted Jul 3, 2007·93 cites·12 claims
- 4993US7226943B2Benzothiepine ileal bile acid transport inhibitorsASTRAZENECA AB·Filed 2002·Granted Jun 5, 2007·80 cites·21 claims
- 5093US7199140B2Vinyl phenyl derivatives as GLK activatorsASTRAZENECA AB·Filed 2002·Granted Apr 3, 2007·52 cites·5 claims
Showing the top 50 of 2,364 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →